IOP monitoring with an implantable sensor predicts visual field progression in the EYEMATE-IO trial

Aims To assess the relationship between intraocular pressure (IOP) measurements and concurrent rates of visual field (VF) progression in primary open-angle glaucoma eyes with a sulcus-implanted IOP sensor system. Methods In this prospective, multicentre trial, eyes implanted with the EYEMATE-IO sensor system were enrolled in the 3-year ARGOS-03 follow-up study. Participants were requested to measure their IOP via the EYEMATE-IO system at least four times a day at different times. Mean IOP, peak IOP and IOP fluctuation were measured by both the EYEMATE-IO sensor and Goldmann applanation tonometry (GAT) during the period between two consecutive VF examinations and their association with VF progression was analysed using mixed-effects models. Results Nine eyes of 9 patients were included. The mean number of IOP measurements per patient between two VF examinations was 4082.8±1550.7 (range 1652–7152) with EYEMATE-IO and 2.1±0.3 (range 2–3) with GAT. The mean follow-up time was 2.9±0.2 years (range 2.4–3.0). Mean IOP measured using the EYEMATE-IO sensor was significantly associated with VF progression (coefficient −0.21 (95% CI −0.34 to −0.07), p=0.003), whereas no association was found for in-office mean IOP measured by GAT (coefficient 0.03 (95% CI −0.12 to 0.05), p=0.450). Similar results were seen when sensor-measured IOP readings during office hours and out-of-office hours were analysed separately. Conclusions Glaucomatous VF progression was associated with mean IOP measured with the EYEMATE-IO sensor, but not with single in-office GAT readings. Continual self-monitoring of IOP with an implantable sensor may better predict glaucomatous VF progression than single in-office GAT readings. Trial registration number NCT03651336.

Authors

Institutions

Publication Details

Journal
British Journal of Ophthalmology
Published
2026-11-16
DOI
https://doi.org/10.1136/bjo-2025-329385
Primary Topic
Glaucoma and retinal disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

IOP monitoring with an implantable sensor predicts visual field progression in the EYEMATE-IO trial

Eleonora Micheletti, Harsha L. Rao, Kaweh Mansouri, Robert Weinreb
1 links
British Journal of Ophthalmology
Glaucoma and retinal disorders
article

IOP monitoring with an implantable sensor predicts visual field progression in the EYEMATE-IO trial

Eleonora Micheletti, Harsha L. Rao, Kaweh Mansouri, Robert Weinreb
article en

Abstract

Aims To assess the relationship between intraocular pressure (IOP) measurements and concurrent rates of visual field (VF) progression in primary open-angle glaucoma eyes with a sulcus-implanted IOP sensor system. Methods In this prospective, multicentre trial, eyes implanted with the EYEMATE-IO sensor system were enrolled in the 3-year ARGOS-03 follow-up study. Participants were requested to measure their IOP via the EYEMATE-IO system at least four times a day at different times. Mean IOP, peak IOP and IOP fluctuation were measured by both the EYEMATE-IO sensor and Goldmann applanation tonometry (GAT) during the period between two consecutive VF examinations and their association with VF progression was analysed using mixed-effects models. Results Nine eyes of 9 patients were included. The mean number of IOP measurements per patient between two VF examinations was 4082.8±1550.7 (range 1652–7152) with EYEMATE-IO and 2.1±0.3 (range 2–3) with GAT. The mean follow-up time was 2.9±0.2 years (range 2.4–3.0). Mean IOP measured using the EYEMATE-IO sensor was significantly associated with VF progression (coefficient −0.21 (95% CI −0.34 to −0.07), p=0.003), whereas no association was found for in-office mean IOP measured by GAT (coefficient 0.03 (95% CI −0.12 to 0.05), p=0.450). Similar results were seen when sensor-measured IOP readings during office hours and out-of-office hours were analysed separately. Conclusions Glaucomatous VF progression was associated with mean IOP measured with the EYEMATE-IO sensor, but not with single in-office GAT readings. Continual self-monitoring of IOP with an implantable sensor may better predict glaucomatous VF progression than single in-office GAT readings. Trial registration number NCT03651336.

British Journal of Ophthalmology
University of California San Diego (US), Narayana Nethralaya (IN), Moorfields Eye Hospital (GB), University of Colorado Anschutz Medical Campus (US), Swisscom (Switzerland) (CH), University of Colorado Denver (US)
Good health and well-being
Glaucoma and retinal disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon